Insulet (PODD) Shares Outstanding (Weighted Average) (2010 - 2026)
Insulet (PODD) reported Shares Outstanding (Weighted Average) of $70.0 million for Q1 2026, little changed on a YoY basis from $70.3 million in Q1 2025, and down 0.51% quarter-over-quarter from $70.3 million in Q4 2025.
Insulet (PODD) Shares Outstanding (Weighted Average) (2010 - 2026) Analysis & Trends
Insulet has reported Shares Outstanding (Weighted Average) for 17 years, with the latest figure at $70.0 million in Q1 2026.
- For the quarter ending Q1 2026, Shares Outstanding (Weighted Average) changed 0.41% year-over-year to $70.0 million; the trailing twelve-month figure through Mar 2026 stood at $70.0 million (changed 0.41% YoY), and the FY2025 full-year result was $70.3 million, changed 0.39% from the prior year.
- Shares Outstanding (Weighted Average) for Q1 2026 stood at $70.0 million, down from $70.3 million in the prior quarter.
- The five-year high for Shares Outstanding (Weighted Average) was $70.4 million in Q2 2025, with the low at $69.3 million in Q1 2022.
- Historically, Shares Outstanding (Weighted Average) has averaged $69.9 million across 5 years, with a median of $70.0 million in 2024.
- Annual changes were most pronounced in 2022 — Shares Outstanding (Weighted Average) climbed 4.75% — and 2026, when it declined 0.41%.
- Insulet's Shares Outstanding (Weighted Average) stood at $69.4 million in 2022, then gained by 0.54% to $69.8 million in 2023, then gained by 0.47% to $70.1 million in 2024, then rose by 0.39% to $70.3 million in 2025, then retreated by 0.51% to $70.0 million in 2026.
- The last three Shares Outstanding (Weighted Average) figures came in at $70.0 million (Q1 2026), $70.3 million (Q4 2025), and $70.4 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares (Weighted Avg.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | 1.74 Bn |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | 382.90 Mn |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | 1.28 Bn |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | 1.48 Bn |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | 579.20 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | 385.10 Mn |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | 456.00 Mn |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | 98.20 Mn |
| 10 | Insulet | 10.20 Bn | 9.72 Bn | 529.10 Mn | 69.99 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 69.99 Mn |
| Dec 31, 2025 | 70.35 Mn |
| Sep 30, 2025 | 70.37 Mn |
| Jun 30, 2025 | 70.39 Mn |
| Mar 31, 2025 | 70.27 Mn |
| Dec 31, 2024 | 70.08 Mn |
| Sep 30, 2024 | 70.05 Mn |
| Jun 30, 2024 | 70.06 Mn |
| Mar 31, 2024 | 69.96 Mn |
| Dec 31, 2023 | 69.75 Mn |
| Sep 30, 2023 | 69.72 Mn |
| Jun 30, 2023 | 69.74 Mn |
| Mar 31, 2023 | 69.58 Mn |
| Dec 31, 2022 | 69.38 Mn |
| Sep 30, 2022 | 69.42 Mn |
| Jun 30, 2022 | 69.31 Mn |
| Mar 31, 2022 | 69.25 Mn |
| Dec 31, 2021 | 67.70 Mn |
| Sep 30, 2021 | 67.24 Mn |
| Jun 30, 2021 | 66.41 Mn |